These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17348446)

  • 21. Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan.
    Wu MH; Chu CH; Chou YC; Chou WY; Yang T; Hsu GC; Yu CP; Yu JC; Sun CA
    Breast Cancer Res Treat; 2011 Jun; 127(3):777-84. PubMed ID: 21140205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.
    Vogel U; Christensen J; Nexø BA; Wallin H; Friis S; Tjønneland A
    Carcinogenesis; 2007 Feb; 28(2):427-34. PubMed ID: 16959787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
    Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
    Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
    Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.
    Hartikainen JM; Tuhkanen H; Kataja V; Eskelinen M; Uusitupa M; Kosma VM; Mannermaa A
    Clin Cancer Res; 2006 Mar; 12(5):1454-62. PubMed ID: 16533768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
    Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
    Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U; Wolf G; Langsenlehner T; Gerger A; Hofmann G; Clar H; Wascher TC; Paulweber B; Samonigg H; Krippl P; Renner W
    Breast Cancer Res Treat; 2008 May; 109(2):297-304. PubMed ID: 17636397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
    Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
    Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence.
    Stevens VL; McCullough ML; Pavluck AL; Talbot JT; Feigelson HS; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1140-7. PubMed ID: 17548676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in adiposity-related genes are associated with age at menarche and menopause in breast cancer patients and healthy women.
    Kim KZ; Shin A; Lee YS; Kim SY; Kim Y; Lee ES
    Hum Reprod; 2012 Jul; 27(7):2193-200. PubMed ID: 22537818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine gene polymorphisms and breast cancer susceptibility.
    Scola L; Vaglica M; Crivello A; Palmeri L; Forte GI; Macaluso MC; Giacalone A; Di Noto L; Bongiovanni A; Raimondi C; Accardo A; Verna R; Candore G; Caruso C; Lio D; Palmeri S
    Ann N Y Acad Sci; 2006 Nov; 1089():104-9. PubMed ID: 17261759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between polymorphisms in LEP, LEPR, ADIPOQ, ADIPOR1, or ADIPOR2 and postmenopausal breast cancer risk.
    Teras LR; Goodman M; Patel AV; Bouzyk M; Tang W; Diver WR; Feigelson HS
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2553-7. PubMed ID: 19723917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.